1. Home
  2. MREO vs CWBC Comparison

MREO vs CWBC Comparison

Compare MREO & CWBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • CWBC
  • Stock Information
  • Founded
  • MREO 2015
  • CWBC 1989
  • Country
  • MREO United Kingdom
  • CWBC United States
  • Employees
  • MREO N/A
  • CWBC N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • CWBC Major Banks
  • Sector
  • MREO Health Care
  • CWBC Finance
  • Exchange
  • MREO Nasdaq
  • CWBC Nasdaq
  • Market Cap
  • MREO 438.8M
  • CWBC 398.6M
  • IPO Year
  • MREO N/A
  • CWBC 1996
  • Fundamental
  • Price
  • MREO $1.74
  • CWBC $20.13
  • Analyst Decision
  • MREO Strong Buy
  • CWBC Buy
  • Analyst Count
  • MREO 5
  • CWBC 3
  • Target Price
  • MREO $7.20
  • CWBC $21.67
  • AVG Volume (30 Days)
  • MREO 1.8M
  • CWBC 46.9K
  • Earning Date
  • MREO 08-12-2025
  • CWBC 07-17-2025
  • Dividend Yield
  • MREO N/A
  • CWBC 2.37%
  • EPS Growth
  • MREO N/A
  • CWBC 95.72
  • EPS
  • MREO N/A
  • CWBC 1.39
  • Revenue
  • MREO $500,000.00
  • CWBC $132,829,000.00
  • Revenue This Year
  • MREO N/A
  • CWBC $30.64
  • Revenue Next Year
  • MREO $38.38
  • CWBC $6.58
  • P/E Ratio
  • MREO N/A
  • CWBC $14.53
  • Revenue Growth
  • MREO N/A
  • CWBC 55.84
  • 52 Week Low
  • MREO $1.47
  • CWBC $15.57
  • 52 Week High
  • MREO $5.02
  • CWBC $22.89
  • Technical
  • Relative Strength Index (RSI)
  • MREO 44.98
  • CWBC 56.41
  • Support Level
  • MREO $1.64
  • CWBC $18.51
  • Resistance Level
  • MREO $1.78
  • CWBC $20.48
  • Average True Range (ATR)
  • MREO 0.09
  • CWBC 0.50
  • MACD
  • MREO 0.04
  • CWBC 0.09
  • Stochastic Oscillator
  • MREO 87.10
  • CWBC 82.23

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About CWBC Community West Bancshares

Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.

Share on Social Networks: